100M SARS-COV-2 MRNA-1273 VACCINE DOSES
$8,204,906,278
| Recipient | MODERNATX, INC. UEI WJYNZ8AK2D47 |
|---|---|
| Award ID | W911QY20C0100 |
| Award amount | $8,204,906,278 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Defense — Department of the Army |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Start date | Aug 11, 2020 |
| End date | Jun 30, 2023 |
| Place of performance | CAMBRIDGE, MA |
| Record updated | Dec 31, 2025 |
View the official award record
More awards won by MODERNATX, INC.
DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN 0003 - DOMESTIC MANUFACTURING SCALE-OUT
Department of Health and Human Services · $1,754,345,480 · Apr 3, 2020
MODERNA THERAPEUTICS, INC:ADVANCE THE DEVELOPMENT OF AN MRNA VACCINE FOR THE PREVENTION OF ZIKA VIRUS:: IGF::OT::IGF
Department of Health and Human Services · $72,971,523 · Sep 1, 2016
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids